06/13
Headlines

Arena Pharmaceuticals

Trader’s Recap – SINA (NASDAQ:SINA) , Arena Pharmaceuticals (NASDAQ:ARNA) , FelCor Lodging Trust (NYSE:FCH) , Anixter (NYSE:AXE) , Genomic (NASDAQ:GHDX)

Jason Knox03 mins

SINA Corp (NASDAQ:SINA)‘s stock had its “neutral” rating reiterated by Zacks in a research report issued to clients and investors on Thursday. They currently have a $52.00 target price on the stock. Zacks‘s target price suggests a potential upside of 4.75% from the stock’s previous close. SINA Corp (NASDAQ:SINA) stock performance was -0.38% in last…

Read More

Volatile Stocks: Canadian Solar (NASDAQ:CSIQ), Genetic Technologies (NASDAQ:GENE), Dendreon (NASDAQ:DNDN), Arena Pharmaceuticals (NASDAQ:ARNA)

Kevin Long03 mins

Canadian Solar Inc. (NASDAQ:CSIQ) on July 7th, 2014 announced that its wholly owned subsidiary, Canadian Solar Solutions Inc., on June 30th, completed the sale of the 10 MW AC solar photovoltaic (PV) power plant “Val Caron” valued at over CAD 60 million to One West Holdings Ltd., an affiliate of Concord Green Energy. Canadian Solar Inc….

Read More

Healthcare Active Movers: Pfizer Inc. (NYSE:PFE), Arena Pharmaceuticals (NASDAQ:ARNA), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)

Mark Doerr02 mins

CliniWorks today announced a strategic alliance between and Pfizer Inc. (NYSE:PFE) to jointly advance the parties’ respective capabilities in working with healthcare provider organizations to identify and close clinical or quality gaps to improve population health. The two companies are partnering to develop a population health management platform solution that leverages CliniWorks’ technologies in disparate…

Read More